T. Maurin

发表

Identification of Keratinocyte Growth Factor as a Target of microRNA-155 in Lung Fibroblasts: Implication in Epithelial-Mesenchymal Interactions

P. Barbry, B. Mari, N. Pottier, 2009, PloS one.

miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity

P Barbry, J. Pouysségur, N. Mazure, 2011, Cell Death and Differentiation.

Suppression of MicroRNA-Silencing Pathway by HIV-1 During Virus Replication

Pascal Barbry, Bernard Mari, Kuan-Teh Jeang, 2007, Science.

Fragile X Syndrome: From molecular pathology to therapy

B. Bardoni, T. Maurin, Samantha Zongaro, 2014, Neuroscience & Biobehavioral Reviews.

Antilogic, a new supervised machine learning software for the automatic interpretation of antibiotic susceptibility testing in clinical microbiology: proof-of-concept on three frequently isolated bacterial species.

D. Raoult, J. Rolain, T. Maurin, 2022, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Anesthesia-induced hypothermia mediates decreased ARC gene and protein expression through ERK/MAPK inactivation

J. Charron, T. Maurin, L. Virág, 2013, Scientific Reports.

Tumor necrosis factor-α stimulates HIV-1 production in primary culture of human adipocytes

L. Pénicaud, B. Cousin, L. Casteilla, 2005 .

Ars2 maintains neural stem cell identity via direct transcriptional activation of Sox2

E. Lai, C. Thompson, T. Maurin, 2011, Nature.

A peptide derived from bee venom-secreted phospholipase A2 inhibits replication of T-cell tropic HIV-1 strains via interaction with the CXCR4 chemokine receptor.

G. Lambeau, T. Maurin, A. Doglio, 2001, Molecular pharmacology.

Transcriptional Regulation of β-Secretase by p25/cdk5 Leads to Enhanced Amyloidogenic Processing

Bryan Maloney, D. Lahiri, Lili Wang, 2008, Neuron.

Neurotoxicity and other pharmacological activities of the snake venom phospholipase A2 OS2: the N-terminal region is more important than enzymatic activity.

M. Gelb, M. Lazdunski, G. Lambeau, 2006, Biochemistry.

Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis

E. Lai, D. O’Carroll, N. Robine, 2010, Proceedings of the National Academy of Sciences.

expression of key cancer proteins in acute promyelocytic leukemia Transcriptional repression of microRNA genes by PML-RARA increases

W. Wasserman, E. Portales-Casamar, P. Barbry, 2013 .

Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia.

Elodie Portales-Casamar, Pascal Barbry, Wyeth W Wasserman, 2009, Blood.

Functional parameters of Dicer-independent microRNA biogenesis.

E. Lai, T. Maurin, Jr-Shiuan Yang, 2012, RNA.

RNase III-independent microRNA biogenesis in mammalian cells.

E. Lai, T. Maurin, D. Cazalla, 2012, RNA.

Agonist-induced functional analysis and cell sorting associated with single-cell transcriptomics characterizes cell subtypes in normal and pathological brain

J. Cazareth, B. Bardoni, T. Maurin, 2020, Genome research.

Intertwined pathways for Argonaute-mediated microRNA biogenesis in Drosophila

E. Lai, Peter Smibert, J. Westholm, 2013, Nucleic acids research.

The FMRP/GRK4 mRNA interaction uncovers a new mode of binding of the Fragile X mental retardation protein in cerebellum

E. Bechara, L. Davidovic, Mireille Melko, 2015, Nucleic acids research.

New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes

P. Szatmari, A. Giangrande, I. Caillé, 2017, Disease Models & Mechanisms.

A new cis-acting motif is required for the axonal SMN-dependent Anxa2 mRNA localization.

B. Bardoni, T. Maurin, R. Bordonné, 2017, RNA.

Reduction of Fmr1 mRNA Levels Rescues Pathological Features in Cortical Neurons in a Model of FXTAS

E. Lalli, B. Bardoni, R. Willemsen, 2019, Molecular therapy. Nucleic acids.

Fragile X Mental Retardation Protein: To Be or Not to Be a Translational Enhancer

B. Bardoni, T. Maurin, 2018, Front. Mol. Biosci..

The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?

B. Bardoni, T. Maurin, S. Castagnola, 2017, Front. Synaptic Neurosci..

New Insights Into the Role of Cav2 Protein Family in Calcium Flux Deregulation in Fmr1-KO Neurons

B. Bardoni, T. Maurin, A. Paquet, 2018, Front. Mol. Neurosci..

Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.

B. Bardoni, V. Trezza, T. Maurin, 2018, Cerebral cortex.

HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein

B. Bardoni, T. Maurin, K. Lebrigand, 2018, Nucleic acids research.

Exploration and characterisation of the phenotypic and genetic profiles of patients with early onset schizophrenia associated with autism spectrum disorder and their first-degree relatives: a French multicentre case series study protocol (GenAuDiss)

B. Bardoni, T. Maurin, Małgorzata Drozd, 2018, BMJ Open.

Sumoylation regulates FMRP-mediated dendritic spine elimination and maturation

B. Bardoni, R. Gautier, T. Maurin, 2018, Nature Communications.

Agonist-induced Functional Analysis and Cell Sorting, a novel tool to select and analyze neurons: Fragile X as a proof of concept

J. Cazareth, B. Bardoni, T. Maurin, 2020, bioRxiv.

An envelope-determined endocytic route of viral entry allows HIV-1 to escape from secreted phospholipase A2 entry blockade.

G. Lambeau, T. Maurin, A. Doglio, 2007, Journal of molecular biology.

Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia.

W. Wasserman, E. Portales-Casamar, P. Barbry, 2009, Blood.

RNase III-independent microRNA biogenesis in mammalian cells.

E. Lai, T. Maurin, D. Cazalla, 2012, RNA.

Tumor necrosis factor-alpha stimulates HIV-1 production in primary culture of human adipocytes.

L. Pénicaud, B. Cousin, L. Casteilla, 2005, Experimental Cell Research.